Vigo is pleased to have been appointed by Acercor Therapeutics as strategic communications adviser to enhance their corporate reputation and investor communications. AIM-listed Arecor is a biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic disease.
Vigo is pleased to have been appointed by Acercor Therapeutics as strategic communications adviser to enhance their corporate reputation and investor communications. AIM-listed Arecor is a biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic disease.